G. Beck

891 total citations
57 papers, 741 citations indexed

About

G. Beck is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, G. Beck has authored 57 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Genetics and 14 papers in Pharmacology. Recurrent topics in G. Beck's work include Estrogen and related hormone effects (14 papers), Pharmacogenetics and Drug Metabolism (12 papers) and RNA and protein synthesis mechanisms (7 papers). G. Beck is often cited by papers focused on Estrogen and related hormone effects (14 papers), Pharmacogenetics and Drug Metabolism (12 papers) and RNA and protein synthesis mechanisms (7 papers). G. Beck collaborates with scholars based in France, Germany and Hungary. G. Beck's co-authors include Sylvette Chasserot‐Golaz, Jean‐Pierre Ebel, R. Röschenthaler, G. Dirheimer, Geneviève Aubel‐Sadron, A. Belarbi, Fernand Labrie, D. Philibert, M.M. Bouton and Catherine Schuster and has published in prestigious journals such as Nature, Journal of Molecular Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

G. Beck

56 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Beck France 15 358 165 127 108 97 57 741
O. v. Deimling Germany 22 774 2.2× 153 0.9× 83 0.7× 105 1.0× 94 1.0× 98 1.4k
C.C. Widnell Tanzania 11 990 2.8× 238 1.4× 266 2.1× 76 0.7× 94 1.0× 12 1.6k
J Chauveau France 14 1.0k 2.8× 128 0.8× 82 0.6× 75 0.7× 178 1.8× 39 1.6k
Roger E. Ganschow United States 13 438 1.2× 158 1.0× 102 0.8× 44 0.4× 25 0.3× 19 756
Claudia T. Evans United States 18 587 1.6× 294 1.8× 69 0.5× 24 0.2× 77 0.8× 33 919
Fu‐Li Yu United States 17 613 1.7× 118 0.7× 47 0.4× 130 1.2× 78 0.8× 37 871
F. R. Mangan United Kingdom 12 215 0.6× 142 0.9× 239 1.9× 31 0.3× 50 0.5× 26 634
G. Prem‐Veer Reddy United States 20 654 1.8× 100 0.6× 45 0.4× 81 0.8× 161 1.7× 42 1.1k
John S. Schweppe United States 17 579 1.6× 130 0.8× 82 0.6× 22 0.2× 78 0.8× 40 852
Yosef Graziani Israel 14 412 1.2× 91 0.6× 34 0.3× 61 0.6× 70 0.7× 21 643

Countries citing papers authored by G. Beck

Since Specialization
Citations

This map shows the geographic impact of G. Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Beck more than expected).

Fields of papers citing papers by G. Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Beck. The network helps show where G. Beck may publish in the future.

Co-authorship network of co-authors of G. Beck

This figure shows the co-authorship network connecting the top 25 collaborators of G. Beck. A scholar is included among the top collaborators of G. Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Beck. G. Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nanda, I., et al.. (2001). Human puromycin-sensitive aminopeptidase: cloning of 3′ UTR, evidence for a polymorphism at aa 140 and refined chromosomal localization to 17q21. Cytogenetic and Genome Research. 92(3-4). 221–224. 6 indexed citations
2.
Schuster, Catherine, Sylvette Chasserot‐Golaz, & G. Beck. (1993). Antiproliferative action of the steroid RU486 in cultured human lymphoma cells. Cancer Letters. 71(1-3). 43–50. 1 indexed citations
3.
Chasserot‐Golaz, Sylvette, G. Beck, & A. Venetianer. (1993). Biotransformation of 17β-hydroxy-11β-(4-dimethylaminophenyl)17α-1-propynyl-estra-4,9-dien-3-one (RU486) in rat hepatoma variants. Biochemical Pharmacology. 46(11). 2100–2103. 7 indexed citations
4.
Chasserot‐Golaz, Sylvette & G. Beck. (1992). How the potency of the steroid RU486 is related to P450 activities induced by dexamethasone and phenobarbital in rat hepatoma cells. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 653–657. 9 indexed citations
5.
Schuster, Catherine, et al.. (1991). Evidence for a Functional Glucocorticoid Responsive Element in the Epstein-Barr Virus Genome. Molecular Endocrinology. 5(2). 267–272. 13 indexed citations
6.
Schuster, Catherine, Sylvette Chasserot‐Golaz, & G. Beck. (1991). Activation of Epstein‐Barr virus promoters by a growth‐factor and a glucocorticoid. FEBS Letters. 284(1). 82–86. 21 indexed citations
7.
Chasserot‐Golaz, Sylvette, et al.. (1990). The steroid antagonist RU38486 is metabolized by the liver microsomal P450 mono-oxygenases. Biochemical and Biophysical Research Communications. 167(3). 1271–1278. 10 indexed citations
8.
Schuster, Catherine, Sylvette Chasserot‐Golaz, & G. Beck. (1989). Binding studies of the antiglucocorticoid RU38486 in Daudi and Raji lymphoma cells. Journal of Steroid Biochemistry. 34(1-6). 461–465. 2 indexed citations
9.
Dietrich, Jean‐Bernard, et al.. (1988). Structural and immunochemical properties of rat liver tyrosine aminotransferase. Biochimie. 70(5). 673–679. 3 indexed citations
10.
Chasserot‐Golaz, Sylvette, et al.. (1988). Antagonistic action of RU38486 on the activity of transforming growth factor-β in fibroblasts and lymphoma cells. Journal of Steroid Biochemistry. 30(1-6). 381–385. 18 indexed citations
11.
Dietrich, J, et al.. (1987). Integrity of the C-terminal part of tyrosine aminotransferase revealed by an anti-peptide serum. Biochemical and Biophysical Research Communications. 144(2). 801–806. 2 indexed citations
12.
Rihn, Bertrand, et al.. (1985). Effect of the cytotoxin of Clostridium difficile on cultured hepatoma cells. Biology of the Cell. 53(1). 23–32. 9 indexed citations
13.
Chasserot‐Golaz, Sylvette & G. Beck. (1984). An approach to the mechanism of the potent antiglucocorticoid: 17β-hydroxy- 11β -4-dimethylaminophenyl-17α- propynyl-estra-4,9-dien-3-one. Journal of Steroid Biochemistry. 21(5). 585–591. 28 indexed citations
14.
Beck, G., et al.. (1981). Inhibition of tyrosine aminotransferase induction by UTP deficiency and its reversal by 5-fluorouridine in cultured hepatoma cells. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 655(1). 34–40. 2 indexed citations
15.
Weber, Anne, Christiane Guguen‐Guillouzo, Marie‐France Szajnert, G. Beck, & F Schapira. (1980). Tyrosine Aminotransferase in Senescent Rat Liver. Gerontology. 26(1). 9–15. 4 indexed citations
16.
Belarbi, A., et al.. (1977). Purification and characterization of rat liver tyrosine aminotransferase. FEBS Letters. 75(1-2). 221–225. 26 indexed citations
17.
Ebel, Jean‐Pierre, et al.. (1969). Inhibition de la multiplication virale á l'aide d'acides ribonuclêiques chimiquement modifiès: III Influence de la nature et du taux des modifications. Chemico-Biological Interactions. 1(2). 157–164. 2 indexed citations
18.
Ebel, Jean‐Pierre, et al.. (1969). Study of the Therapeutic Effect on Irradiated Mice of Substances Contained in RNA Preparations. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 16(3). 201–209. 4 indexed citations
19.
Hirth, Léon, Geneviève Lebeurier, Geneviève Aubel‐Sadron, et al.. (1960). Influence of a Quaternary Ammonium Salt on the Infectivity of Ribonucleic Acid from Tobacco Mosaic Virus. Nature. 188(4751). 689–689. 6 indexed citations
20.
Aubel‐Sadron, Geneviève, G. Beck, Jean‐Pierre Ebel, & Charles Sadron. (1960). Etude de la précipitation des acides nucléiques par les sels d'ammonium quaternaire. Biochimica et Biophysica Acta. 42. 542–543. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O. v. Deimling Breakdown of academic impact, for papers by C.C. Widnell Breakdown of academic impact, for papers by J Chauveau Breakdown of academic impact, for papers by Roger E. Ganschow Breakdown of academic impact, for papers by Claudia T. Evans Breakdown of academic impact, for papers by Fu‐Li Yu Breakdown of academic impact, for papers by F. R. Mangan Breakdown of academic impact, for papers by G. Prem‐Veer Reddy Breakdown of academic impact, for papers by John S. Schweppe Breakdown of academic impact, for papers by Yosef Graziani
Rankless by CCL
2026